This finding aligns with our previous report identifying an M1‐like TAM subset with antitumour properties through CXCL9/10/11 expression,13 and prior studies reporting that CXCL9/10/11‐producing macrophages and DCs enhance lymphocyte infiltration and sensitise tumours to immune checkpoint blockade.76 The gene discussed is CXCL9; the disease is neoplasm.